The identification of neuropeptide y receptor subtype involved in phenylpropanolamine-induced increase in oxidative stress and appetite suppression

NeuroMolecular Medicine

Volumn 15, Issue 1, 2013, Pages 159-168

  Hsieh, Yih Shou ^a   Kuo, Meng Hsien ^b   Chen, Pei Ni ^a   Kuo, Dong Yih ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b National Taichung Second Senior High School   (Taiwan)

Author keywords

Antisense; Brain; NPY receptor; SOD; Y1R and Y5R inhibitors

Indexed keywords

MANGANESE SUPEROXIDE DISMUTASE; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; PHENYLPROPANOLAMINE;

ANIMAL EXPERIMENT; ANOREXIA; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DRUG DOSE COMPARISON; EVENING DOSAGE; FEEDING BEHAVIOR; FOOD INTAKE; GENE SILENCING; HYPOTHALAMUS; MALE; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; TOXICOLOGY; TREATMENT DURATION;

ANIMALS; ANOREXIA; APPETITE; APPETITE DEPRESSANTS; GENE KNOCKDOWN TECHNIQUES; HYPOTHALAMUS; INJECTIONS, INTRAVENTRICULAR; MALE; NEUROPEPTIDE Y; OLIGONUCLEOTIDES, ANTISENSE; OXIDATIVE STRESS; PHENYLPROPANOLAMINE; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; RECEPTORS, NEUROPEPTIDE Y; SUPEROXIDE DISMUTASE; SYMPATHOMIMETICS;

RATTUS NORVEGICUS;

EID: 84874744829     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-012-8206-x     Document Type: Article

References (50)

1. Acuna-Goycolea, C.; & van den Pol, A. N. (2005). Peptide YY(3-36) inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: Implications for hypothalamic regulation of energy homeostasis. Journal of Neuroscience, 25, 10510-10519. (Pubitemid 41628453)
2. Campbell, R. E.; Ffrench-Mullen, J. M.; Cowley, M. A.; Smith, M. S.; & Grove, K. L. (2001). Hypothalamic circuitry of neuropeptide Y regulation of neuroendocrine function and food intake via the Y5 receptor subtype. Neuroendocrinology, 74, 106-119. (Pubitemid 32727577)
3. Chee, M. J.; & Colmers, W. F. (2008). Y eat? Nutrition, 24, 869-877.
4. Chee, M. J.; Myers, M. G.; Jr, Price, C. J.; & Colmers, W. F. (2010). Neuropeptide Y suppresses anorexigenic output from the ventromedial nucleus of the hypothalamus. Journal of Neuroscience, 30, 3380-3390.
5. Cheng, J. T.; & Kuo, D. Y. (2003). Both α1-adrenergic and D1-dopaminergic neurotransmissions are involved in phenylpropanolamine-mediated feeding suppression in mice. Neuroscience Letter, 347, 136-138. (Pubitemid 36836233)
6. Cowley, M. A.; Pronchuk, N.; Fan, W.; Dinulescu, D. M.; Colmers, W. F.; & Cone, R. D. (1999). Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: Evidence of a cellular basis for the adipostat. Neuron, 24, 155-163. (Pubitemid 29466155)
7. Eva, C.; Serra, M.; Mele, P.; Panzica, G.; & Oberto, A. (2006). Physiology and gene regulation of the brain NPY Y1 receptor. Frontier Neuroendocrinology, 27, 308-339. (Pubitemid 44548041)
8. Gao, J.; Ghibaudi, L.; & Hwa, J. J. (2004). Selective activation of central NPY Y1 vs. Y5 receptor elicits hyperinsulinemia via distinct mechanisms. American Journal of Physiology- Endocrinology and Metabolism, 287, E706-E711. (Pubitemid 39237899)
9. Gerald, C.; Walker, M. W.; Criscione, L.; Gustafson, E. L.; Batzl-Hartmann, C.; Smith, K. E.; et al. (1996). A receptor subtype involved in neuropeptide-Y-induced food intake. Nature, 382, 168-171. (Pubitemid 26242883)
10. Goodhue, A.; Bartel, R. L.; & Smith, N. B. (2000). Exacerbation of psychosis by phenylpropanolamine. American Journal of Psychiatry, 157, 1021-1022.
11. Heilig, M. (1995). Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. Regulatory Peptide, 59, 201-205.
12. Higuchi, H.; Niki, T.; & Shiiya, T. (2008). Feeding behavior and gene expression of appetite-related neuropeptides in mice lacking for neuropeptide Y Y5 receptor subclass. World Journal of Gastroenterology, 14, 6312-6317.
13. Horvath, T. L.; Andrews, Z. B.; & Diano, S. (2009). Fuel utilization by hypothalamic neurons: Roles for ROS. Trends Endocrinology and Metabolism, 20, 78-87.
14. Hsieh, Y. S.; Hsu, J. D.; Yang, S. F.; & Kuo, D. Y. (2004). Immunohistochemical and genomic evidence for the involvement of hypothalamic neuropeptide Y in phenylpropranolamine-mediated appetite suppression. Peptides, 25, 2155-2161. (Pubitemid 39574458)
15. Hsieh, Y. S.; Yang, S. F.; Chiou, H. L.; & Kuo, D. Y. (2007). Roles of central catecholamine and hypothalamic neuropeptide Y genome in the development of tolerance to phenylpropanolamine-mediated appetite suppression. Behavioral Neuroscience, 121, 933-940. (Pubitemid 350051296)
16. Hsieh, Y. S.; Yang, S. F.; Chu, S. C.; Ho, Y. J.; Kuo, C. S.; & Kuo, D. Y. (2008). Transcriptional interruption of cAMP response element binding protein modulates superoxide dismutase and neuropeptide Y-mediated feeding behavior in freely moving rats. Journal of Neurochemistry, 105, 1438-1449. (Pubitemid 351590803)
17. Ibrahim, N.; Bosch, M. A.; Smart, J. L.; Qiu, J.; Rubinstein, M.; Rønnekleiv, O. K.; et al. (2003). Hypothalamic proopiomelanocortin neurons are glucose responsive and express KATP channels. Endocrinology, 144, 1331-1340. (Pubitemid 36428475)
18. Ishihara, A.; Kanatani, A.; Mashiko, S.; Tanaka, T.; Hidaka, M.; Gomori, A.; et al. (2006). A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice. Proceedings of the National Academy of Sciences of the United States of America, 103, 7154-7158.
19. Jaillard, T.; Roger, M.; Galinier, A.; Guillou, P.; Benani, A.; Leloup, C.; et al. (2009). Hypothalamic reactive oxygen species are required for insulin-induced food intake inhibition: An NADPH oxidase-dependent mechanism. Diabetes, 58, 1544-1549.
20. Kask, A.; & Harro, J. (2000). Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide Y Y(1) receptor antagonist BIBO 3304. Neuropharmacology, 39, 1292-1302. (Pubitemid 30173193)
21. Kuo, D. Y.; Chen, P. N.; Chu, S. C.; & Hsieh, Y. S. (2012). Knocking down the transcript of NF-kappa B modulates the reciprocal regulation of endogenous antioxidants and feeding behavior in phenylpropanolamine-treated rats. Archives Toxicology, 86, 453-463.
22. Kuo, D. Y.; Chen, P. N.; Yang, S. F.; Chu, S. C.; Chen, C. H.; Kuo, M. S.; et al. (2011). Role of reactive oxygen species-related enzymes in neuropeptide Y and proopiomelanocortin-mediated appetite control: A study using atypical protein kinase C knockdown. Antioxidant and Redox Signalings, 15, 2147-2159.
23. Kuo, D. Y.; Yang, S. F.; Chu, S. C.; Chen, C. H.; & Hsieh, Y. S. (2009). Roles of protein kinase C-α isozyme in the regulation of oxidative stress and neuropeptide Y gene expression in phenylpropanolamine-mediated appetite suppression. Journal of Neurochemistry, 108, 1495-1506.
24. Lecklin, A.; Lundell, I.; Salmela, S.; Männistö, P. T.; Beck-Sickinger, A. G.; & Larhammar, D. (2003). Agonists for neuropeptide Y receptors Y1 and Y5 stimulate different phases of feeding in guinea pigs. British Journal of Pharmacology, 139, 1433-1440. (Pubitemid 37174657)
25. Lectez, B.; Jeandel, L.; El-Yamani, F. Z.; Arthaud, S.; Alexandre, D.; Mardargent, A.; et al. (2009). The orexigenic activity of the hypothalamic neuropeptide 26RFa is mediated by the neuropeptide Y and proopiomelanocortin neurons of the arcuate nucleus. Endocrinology, 150, 2342-2350.
26. Maric, T.; Sedki, F.; Chafetz, D.; Schoela, N.; & Shalev, U. (2011). A role for neuropeptide Y Y5 but not the Y1-receptor subtype in food deprivation-induced reinstatement of heroin seeking in the rat. Psychopharmacology (Berl), 218, 693-701.
27. Mashiko, S.; Moriya, R.; Ishihara, A.; Gomori, A.; Matsushita, H.; Egashira, S.; et al. (2009). Synergistic interaction between neuropeptide Y1 and Y5 receptor pathways in regulation of energy homeostasis. European Journal of Pharmacology, 615, 113-117.
28. Michel, M. C.; Beck-Sickinger, A.; Cox, H. X. V. I.; et al. (1998). International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacology Review, 50, 143-150. (Pubitemid 28158845)
29. Morin, S. M.; & Gehlert, D. R. (2006). Distribution of NPY Y5-like immunoreactivity in the rat brain. Journal of Molecular Neuroscience, 29, 109-114. (Pubitemid 44352534)
30. Nakamura, M.; Sakanaka, C.; Aoki, Y.; Ogasawara, H.; Tsuji, T.; Kodama, H.; et al. (1995). Identification of two isoforms of mouse neuropeptide Y-Y1 receptor generated by alternative splicing. Isolation, genomic structure, and functional expression of the receptors. Journal of Biological Chemistry, 270, 30102-30110.
31. Ogawa, S.; & Pfaff, D. W. (1998). Current status of antisense DNA methods in behavioral studies. Chemical Senses, 23, 249-255. (Pubitemid 28159969)
32. Okahisa, Y.; Ujike, H.; Kotaka, T.; Morita, Y.; Kodama, M.; Inada, T.; et al. (2009). Association between neuropeptide Y gene and its receptor Y1 gene and methamphetamine dependence. Psychiatry of Clinical Neuroscience, 63, 417-422.
33. O'Shea, D.; Morgan, D.G.; Meeran, K.; Edwards, C.M.; Turton, M.D.; Choi, S.J.; et al. (1997). Neuropeptide Y induced feeding in the rat is mediated by a novel receptor. Endocrinology, 138, 196-202. (Pubitemid 27009424)
34. Paxinos, G.; & Watson, C. (1986). The rat brain in stereotaxic coordinates (2nd ed.). Sydney: Academic Press.
35. Penzner, J. H.; Thompson, D. L.; Arth, C.; Fowler, J. K.; Ary, A. W.; & Szumlinski, K. K. (2008). Protracted 'anti-addictive' effects of adolescent phenylpropanolamine exposure in C57BL/6J mice. Addict Biol, 13, 310-325.
36. Pilsczek, F. H.; Karcic, A. A.; & Freeman, I. (2003). Case report: Dexatrim (Phenylpropanolamine) as a cause of myocardial infarction. Heart and Lung, 32, 100-104. (Pubitemid 36529988)
37. Ritter, R. C.; Slusser, P. G.; & Stone, S. (1981). Glucoreceptors controlling feeding and blood glucose: Location in the hindbrain. Science, 213, 451-452.
38. Rudolf, K.; Eberlein, W.; Engel, W.; Wieland, H.A.; Willim, K.D.; Entzeroth, M.; et al. (1994). The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP 3226. European Journal of Pharmacology, 271, R11-R13.
39. Seif-El-Nasr, M.; Atia, A. S.; & Abdelsalam, R. M. (2008). Effect of MAO-B inhibition against ischemia-induced oxidative stress in the rat brain. Comparison with a rational antioxidant. Arzneimittel-Forschung, 58(160-7), 2008.
40. Szumlinski, K. K.; Liu, A.; Penzner, J. H.; & Lominac, K. D. (2007). Protracted 'pro-addictive' phenotype produced in mice by pre-adolescent phenylpropanolamine. Neuropsychopharmacology, 32, 1760-1773. (Pubitemid 47076386)
41. Tang-Christensen, M.; Kristensen, P.; Stidsen, C. E.; Brand, C. L.; & Larsen, P. J. (1998). Central administration of Y5 receptor antisense decreases spontaneous food intake and attenuates feeding in response to exogenous neuropeptide Y. Journal of Endocrinology, 159, 307-312. (Pubitemid 28520184)
42. Toll, K.; & Graf, P. (2006). Phenylpropanolamine's decongestive effect on the nasalmucosa of pregnant women with nasal stuffiness. Rhinology, 44, 274-277.
43. Tsakiris, P.; de la Rosette, J. J.; Michel, M. C.; & Oelke, M. (2008). Pharmacologic treatment of male stress urinary incontinence: Systematic review of the literature and levels of evidence. European Urology, 53, 53-59. (Pubitemid 350166741)
44. Walker, M.W.; Wolinsky, T.D.; Jubian, V.; Chandrasena, G.; Zhong, H.; Huang, X.; et al. (2009). The novel neuropeptide Y Y5 receptor antagonist Lu AA33810 exerts anxiolytic- and antidepressant-like effects in rat models of stress sensitivity. Journal of Pharmacology and Experimental Therapy, 328, 900-911.
45. Widnell, K. L.; Self, D. W.; Lane, S. B.; Russell, D. S.; Vaidya, V.; Miserendino, M. J. D.; et al. (1996). Regulation of CREB expression: In vivo evidence for a functional role in morphine action in the nucleus accumbens. Journal of Pharmacology and Experimental Therapy, 276, 306-315. (Pubitemid 26150971)
46. Winders, S. E.; Amos, J. C.; Wilson, M. R.; Rushing, P. A.; Dykstra, T.; & Codaym, M. C. (1994). Effects of chronic phenylpropanolamine infusion and termination of body weight, food consumption and water consumption in rats. Psychopharmacology (Berlin), 114, 513-519. (Pubitemid 24153503)
47. Wu, Q.; & Palmiter, R. D. (2011). GABAergic signaling by AgRP neurons prevents anorexia via a melanocortin-independent mechanism. European Journal of Pharmacology, 660, 21-27.
48. Wynne, K.; Stanley, S.; McGowan, B.; & Bloom, S. (2005). Appetite control. Journal of Endocrinology, 184, 291-318. (Pubitemid 40347231)
49. Zhang, M.; & Creese, I. (1993). Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: Behavioral correlates. Neuroscience Letter, 161, 223-226. (Pubitemid 23314873)
50. Zhou, L.; Yueh, C. Y.; Lam, D. D.; Shaw, J.; Osundiji, M.; Garfield, A. S.; et al. (2011). Glucokinase inhibitor glucosamine stimulates feeding and activates hypothalamic neuropeptide Y and orexin neurons. Behavioral Brain Research, 222, 274-278.